Table of Contents
Key Points
- Naltrexone is an FDA-approved medication for treating alcohol use disorder by blocking opioid receptors and reducing alcohol's rewarding effects.
- Standard naltrexone dosing (50 mg daily or 380 mg monthly injection) has strong evidence supporting its effectiveness in reducing heavy drinking.
- Low-dose naltrexone (LDN) refers to smaller doses than standard treatment, but current evidence for its use in alcohol use disorder is limited.
- Naltrexone works best when combined with counseling, support groups, and comprehensive addiction treatment rather than as a standalone solution.
Quick Summary: What You Need to Know About Naltrexone for Alcohol
Naltrexone is an opioid-receptor antagonist approved by the FDA for treating alcohol use disorder (AUD). The clinical evidence supports the use of standard doses, which include 50 mg taken daily by mouth or 380 mg administered monthly by injection [1]. The concept of “low-dose naltrexone” for alcohol treatment involves using smaller amounts than the standard dose, but this approach is less established in treating AUD.
Understanding how naltrexone for alcohol treatment works can help you make informed decisions about your recovery journey. This medication doesn’t cure alcohol use disorder, but when combined with therapy and support, it can significantly reduce cravings and help you maintain your recovery goals [2].
What Is Naltrexone and Why Does It Matter for Alcohol Use?
Naltrexone is a prescription medication that blocks opioid receptors in the brain, changing how your brain responds to alcohol and other substances. The FDA has approved naltrexone [3] for treating both alcohol use disorder and opioid use disorder.
When healthcare providers prescribe naltrexone for AUD treatment, they typically use standard dosing: either 50 mg taken by mouth daily or an extended-release injectable form (brand name Vivitrol) given as a 380 mg injection once monthly. These standard doses have been extensively studied and consistently demonstrate benefits.
The term “low-dose naltrexone” (LDN) typically refers to doses significantly smaller than standard treatment doses, often ranging from 1.5 mg to 4.5 mg daily, or sometimes between 12.5 mg and 25 mg. Low-dose naltrexone has gained attention for various off-label uses (prescribing a medication for a purpose, patient population, dosage, or route of administration that is not listed in its official, FDA-approved labeling or package insert) in conditions like fibromyalgia and autoimmune disorders. However, the evidence supporting low-dose naltrexone specifically for alcohol use disorder remains limited compared to the research backing standard doses.
Naltrexone in Alcohol Use Disorder Treatment: What the Evidence Shows

Standard Dosing and Formats
Research consistently demonstrates that standard-dose naltrexone helps people with alcohol use disorder reduce their drinking. A comprehensive meta-analysis found that oral naltrexone at 50 mg daily was associated with significantly lower rates of heavy drinking [2] compared to placebo.
The injectable extended-release formulation also shows strong results. Clinical trials demonstrate that people receiving monthly naltrexone injections experience fewer drinking days and fewer heavy drinking days compared to placebo. The monthly injection offers an advantage for people who struggle with daily medication adherence [4].
Both formulations work best when combined with psychosocial interventions, including counseling, support groups like AA or SMART Recovery, and behavioral therapy. The medication helps by reducing the physical and neurological pull toward alcohol, while therapy addresses the psychological and behavioral aspects [5] of addiction.
Side Effects or Risks With Naltrexone
Common adverse effects of naltrexone treatment include nausea (especially initially), headache, dizziness, fatigue, and trouble sleeping. With the injectable form, injection site reactions can occur. These side effects are generally mild and often improve after the first week or two. Serious risks are rare but include liver damage at high doses (regular monitoring [1] addresses this) and severe injection site reactions. The most important contraindication is current opioid use, as naltrexone can trigger immediate withdrawal symptoms.
Evidence for Low-Dose Naltrexone in Alcohol Use Disorder
The low-dose naltrexone concept emerged from research into other conditions, where smaller doses were thought to work through different mechanisms. Some clinicians have explored whether these lower doses might benefit people with alcohol use disorder, particularly those who experience side effects at standard doses.
However, current scientific evidence specifically supporting low-dose naltrexone for alcohol use disorder is insufficient to recommend it over standard dosing. The controlled trials that established naltrexone’s effectiveness for AUD used standard doses. Until stronger clinical trials demonstrate that low-dose naltrexone is equally or more effective, standard dosing remains the evidence-based approach.
How Naltrexone Improves Outcomes
When people take naltrexone as prescribed along with psychosocial support, research shows they tend to experience fewer heavy drinking days, consume fewer drinks overall, and achieve better recovery outcomes than those taking placebo [2].
Several factors enhance naltrexone’s effectiveness, including patient motivation, quality of psychosocial support, a period of abstinence before starting naltrexone, and longer treatment duration (generally at least three to six months).
How Does Naltrexone Help With Alcohol Addiction?
When you drink alcohol, your brain releases endorphins that bind to opioid receptors and trigger dopamine release in the brain’s reward pathways. This dopamine surge creates the pleasurable feelings associated with drinking. Over time, your brain strongly associates alcohol with this reward, driving cravings and compulsive drinking.
Naltrexone works by binding to and blocking mu-opioid receptors in the brain. When these receptors are blocked, the endorphins released by alcohol cannot bind effectively. As a result, the dopamine surge is diminished, and alcohol produces less euphoria. This reduction in alcohol’s rewarding effects weakens the reinforcement cycle that maintains addictive drinking.
Naltrexone doesn’t eliminate all desire to drink. Rather, it reduces the reward you experience from drinking, making it easier to resist urges and maintain your commitment to recovery. Many people describe that while on naltrexone, drinking simply becomes less appealing and less satisfying.
Summary
Naltrexone is a well-validated, FDA-approved medication for treating alcohol use disorder. Standard dosing of 50 mg daily orally or 380 mg monthly injection is supported by substantial research evidence showing it reduces heavy drinking [2] when combined with psychosocial treatment.
Low-dose naltrexone for alcohol treatment remains an area of interest but currently lacks the robust evidence base that supports standard dosing. The established effective dose for alcohol use disorder is the standard amount.
Naltrexone works by blocking opioid receptors in the brain, which reduces the endorphin-related reward that alcohol normally produces. This diminished reward makes it easier to resist cravings and maintain recovery goals. The medication provides important neurobiological support, but doesn’t eliminate all desire to drink.
Naltrexone works best when integrated with comprehensive treatment, including counseling, support groups, and behavioral therapy. Medical screening is essential to ensure safety, particularly confirming no opioids are present before starting treatment.
At New Waters Recovery, we incorporate medication-assisted treatment like naltrexone into our comprehensive recovery programs. We provide medical monitoring, individualized care planning, behavioral therapy, and ongoing support to help you achieve lasting recovery from alcohol use disorder.
Frequently Asked Questions
Sources
[1] U.S. Food and Drug Administration. (2010). VIVITROL (naltrexone for extended-release injectable suspension) — Prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021897s015lbl.pdf
[2] Jonas, D. E., Amick, H. R., Feltner, C., et al. (2014). Pharmacotherapy for adults with alcohol use disorders in outpatient settings: A systematic review and meta-analysis. JAMA, 311(18), 1889–1900. https://pubmed.ncbi.nlm.nih.gov/24825644/
[3] NCBI Bookshelf. (2023). Medications for Alcohol Use Disorder (Naltrexone section). National Institutes of Health. https://www.ncbi.nlm.nih.gov/books/NBK64042/
[4] Garbutt, J. C., Kranzler, H. R., O’Malley, S. S., et al. (2005). Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: A randomized controlled trial. JAMA, 293(13), 1617–1625. https://pubmed.ncbi.nlm.nih.gov/15811981/
[5] Substance Abuse and Mental Health Services Administration. (2015). Medication for the Treatment of Alcohol Use Disorder: A Brief Guide (SMA 15-4907). https://store.samhsa.gov/sites/default/files/d7/priv/sma15-4907.pdf
New Waters Recovery Editorial GUIDELINES
At New Waters Recovery, we take your health and wellness seriously. We have a thorough process in place to ensure the integrity of information that is displayed on our website. All content published to our site undergoes a rigorous medical review by a doctorate level clinician to ensure medical accuracy. Read More About Our Process



